Home
Press Releases
- July 23, 2008: Tengion Appoints Mark Stejbach Vice President of Marketing & Commercial Planning
- June 30, 2008: Tengion CEO Dr. Steven Nichtberger Wins Ernst & Young Greater Philadelphia Entrepreneur Of The Year Award®
- June 12, 2008: Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration vs. Repair
- June 11, 2008: Tengion Named One of the Best Places To Work in Industry By the Scientist Magazine
- May 19, 2008: Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder with Tengion Neo-Bladder Replacement™
- May 12, 2008: Tengion to Present Preclinical Data For Regeneration of Entire Bladder
- April 14, 2008: Tengion Appoints David P. Holveck to its Board of Directors
- April 1, 2008: Tengion Announces European Orphan Drug Designation for Neo-Bladder Augment
- February 27, 2008: Tengion Appoints Jeff Randall to Board of Directors
- February 6, 2008: Tengion Featured on CBS Evening News segment "Growing Miracles"
- January 30, 2008:Tengion to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
- January 17, 2008:Tengion to Present at Leerink Swann Novel Biologics Therapeutics Roundtable Conference
- January 3, 2008:Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder
- January 2, 2008:Tengion to Present at 26th Annual JP Morgan Healthcare Conference
- November 1, 2007:Tengion and Company CEO Dr. Steven Nichtberger Featured in The Gray Sheet: "Paving a Path to a Regenerative Medicine Industry"
- October 29, 2007:Preclinical Efficacy Data Demonstrate Ability of Tengion's Neo-Bladder Augment to Restore Bladder Function
- October 15, 2007: Tengion Closes $33 Million in Series C Funding
- September 17, 2007: Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
- April 30, 2007:Tengion Names Dr. Sharon Presnell As VP for Regenerative Medicine & Biology
- January 5, 2007: Tengion Launches First Phase II Clinical Trial of Regenerated Human Organ
- June 23, 2006: Tengion Inc. Completes $50 Million Series "B" Round
- April 18, 2006: Governor Rendell Announces Revolutionary Bioscience Company to Locate Headquarters, Manufacturing Facility in Montgomery County
- April 18, 2006: Tengion Breaks Ground on Human Neo-Organ Manufacturing Facility in Montgomery County, PA
- April 3, 2006: Tengion: Advancing Clinical Development of Laboratory-Grown Human Organs from a Patient's Own Cells
- January 9, 2006: Collaboration Established Between Wake Forest University Health Sciences and Tengion to Advance Regenerative Medicine Research
- September 9, 2005: Tengion Inc. Announces Completion of Executive Leadership Team - Experienced and Proven Team Leading the Company
- August 3, 2005: Tengion Inc. Completes $39 Million Series "A" Round - Financing Will Advance Development of Regenerative Medicine Products